Valuation: Olympus Corporation

Market Cap 1,849B 11.39B 9.96B 9.19B 8.5B 16.14B 1,087B 16.41B 110B 43.13B 534B 42.76B 41.83B P/E 2027 *
19.2x
P/E 2028 * 15.9x
Enterprise Value 1,919B 11.82B 10.34B 9.54B 8.82B 16.75B 1,128B 17.03B 114B 44.76B 554B 44.37B 43.41B EV / Sales 2027 *
1.8x
EV / Sales 2028 * 1.72x
Free-Float
94.53%
Yield 2027 *
1.77%
Yield 2028 * 1.85%
1 day-1.64%
1 week+5.77%
Current month+2.47%
1 month-3.79%
3 months+8.68%
6 months-16.60%
Current year-12.27%
1 week 1,729.5
Extreme 1729.5
1,818
1 month 1,610
Extreme 1610
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%+5.77%+4.82%-21.65% 11.56B
+2.17%-0.48%+24.06%+0.79% 190B
-0.87%-3.21%-21.92%+21.18% 147B
+1.90%-1.75%-3.23%-17.06% 135B
-0.95%-1.30%-56.73%-15.46% 66.6B
-2.62%-3.29%+18.23%-0.41% 53.92B
+0.38%-1.66%-27.47%-30.84% 43.57B
+2.46%+1.27%+9.11%+11.82% 36.45B
+1.74%-1.19%+7.33%+41.61% 36.15B
+0.99%-0.62%-18.61%-3.82% 29.69B
Average +0.38%+1.84%-6.44%-1.38% 74.95B
Weighted average by Cap. +0.69%+1.71%-3.99%+0.18%

Financials

2027 *2028 *
Net sales 1,065B 6.56B 5.74B 5.29B 4.9B 9.29B 626B 9.45B 63.38B 24.85B 308B 24.63B 24.1B 1,107B 6.82B 5.96B 5.5B 5.09B 9.66B 651B 9.82B 65.84B 25.81B 319B 25.58B 25.03B
Net income 98.47B 606M 531M 489M 453M 859M 57.89B 874M 5.86B 2.3B 28.43B 2.28B 2.23B 118B 724M 633M 584M 540M 1.03B 69.11B 1.04B 6.99B 2.74B 33.94B 2.72B 2.66B
Net Debt 69.9B 431M 377M 347M 321M 610M 41.1B 620M 4.16B 1.63B 20.18B 1.62B 1.58B 51.9B 320M 280M 258M 239M 453M 30.51B 460M 3.09B 1.21B 14.98B 1.2B 1.17B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-09 ¥1,741.00 -1.64% 3,166,800
26-07-08 ¥1,770.00 -1.12% 4,558,100
26-07-07 ¥1,790.00 +1.47% 5,393,700
26-07-06 ¥1,764.00 -0.23% 2,337,100
26-07-03 ¥1,768.00 +2.91% 3,647,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,741.00JPY
Average target price
1,913.08JPY
Spread / Average Target
+9.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock